✦ LIBER ✦

Cost-effectiveness and cost-utility of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and tricyclic antidepressants in depression with comorbid cardiovascular disease

✍ Scribed by Pan, Yi-Ju; Kuo, Kuei-Hong; Chan, Hung-Yu; McCrone, Paul

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economics of depression and cost-benefit

✍ Dr. Lewis L. Judd; Mark H. Rapaport 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Effect of Selective Serotonin Reuptake I

✍ Amir A. Sepehry, Philip E. Lee, Ging Yuek R. Hsiung, B. Lynn Beattie… 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 640 KB

Treatment of depression with associated

✍ S. A. Montgomery; R. Judge 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

Length of therapy with selective seroton

✍ Peter McManus; Andrea Mant; Philip Mitchell; John Dudley 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 115 KB

Economic outcomes associated with tricyc

✍ W. H. Crown 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB

The relative effectiveness of selective

✍ C.A. Neslusan; M. Treglia 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 144 KB